US 8372422
Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
granted A61KA61K31/715A61K47/18
Quick answer
US patent 8372422 (Hydroxyapatite-targeting poly(ethylene glycol) and related polymers) held by Nektar Therapeutics expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/715, A61K47/18, A61K47/24, A61K47/60